Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona M Ross

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Blood|May 18, 2006
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myelomaBrian A Walker, Paola E Leone, Matthew W Jenner, et al.
Blood|October 15, 2010
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myelomaBrian A Walker, Christopher P Wardell, Laura Chiecchio, et al.
British Journal of Haematology|April 26, 2002
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisChristine J Harrison, Helen Mazzullo, Fiona M Ross, et al.
British Journal of Haematology|February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatmentPing Wu, Brian A Walker, Daniel Brewer, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Leukemia & Lymphoma|December 29, 2012
Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myelomaAnnamaria Brioli, Martin F Kaiser, Charlotte Pawlyn, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemiaAlicja M Gruszka-Westwood, Sharon W Horsley, Angel Martinez-Ramirez, et al.
Haematologica|May 21, 2009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseLaura Chiecchio, Gian Paolo Dagrada, Rebecca K M Protheroe, et al.
British Journal of Haematology|January 6, 2009
Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemiaKajsa Paulsson, Qian An, Anthony V Moorman, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Blood|May 18, 2006
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myelomaBrian A Walker, Paola E Leone, Matthew W Jenner, et al.
Blood|October 15, 2010
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myelomaBrian A Walker, Christopher P Wardell, Laura Chiecchio, et al.
British Journal of Haematology|April 26, 2002
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisChristine J Harrison, Helen Mazzullo, Fiona M Ross, et al.
British Journal of Haematology|February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatmentPing Wu, Brian A Walker, Daniel Brewer, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Leukemia & Lymphoma|December 29, 2012
Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myelomaAnnamaria Brioli, Martin F Kaiser, Charlotte Pawlyn, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemiaAlicja M Gruszka-Westwood, Sharon W Horsley, Angel Martinez-Ramirez, et al.
Haematologica|May 21, 2009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseLaura Chiecchio, Gian Paolo Dagrada, Rebecca K M Protheroe, et al.
British Journal of Haematology|January 6, 2009
Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemiaKajsa Paulsson, Qian An, Anthony V Moorman, et al.
Pageof 6